Startup profile · funding coverage
Confido Health funding, valuation and investors
Healthcare operations platform built from coordinated AI agents.
Keep track of Confido Health
Save this profile to your VCT watchlist for a quick return.
Funding, valuation & investors
Answer-first snapshotLatest funding
Series A extension
$12.5M · October 2026
Latest known valuation
Not publicly disclosed
Total disclosed equity funding
$26M
Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.
Current status
private
series a · New York, United States
Overview
Confido Health builds CareOS, an agentic operating platform that automates patient calls, scheduling, insurance verification, prescription workflows, payment follow-up and other administrative work for medical practices.
Why Confido Health is interesting
Confido is moving from point voice agents toward a system of action that can coordinate across fragmented healthcare records and workflows. The value depends on accuracy, integration depth and safe escalation to staff.
Product & use cases
CareOS connects AI agents to healthcare systems of record so they can complete operational tasks rather than only store or summarize information.
- Patient scheduling and outbound calls.
- Insurance verification and prescription workflows.
- Payment follow-up and practice operations.
Key facts
- The October extension brings the Series A total to $22.5M.
- CareOS is positioned as a system of action above existing healthcare systems of record.
Funding history (newest first)
Series A extension
2026-10 $12.5M- Z47 (lead)
- Justin Saks (participant)
- Together Fund (participant)
- Blume Ventures (participant)
Series A
2025-09 $10M- Together Fund (participant)
- Blume Ventures (participant)
Seed
2024-12 $3M- Together Fund (participant)
Investors in our directory
Funds linked from Confido Health's profile — open a fund page for stage focus and related deal articles.
Competitive landscape
Edge: A healthcare-specific agent stack that combines voice, workflow integrations and operational orchestration across multi-site practices.
Competes with Hippocratic AI, EliseAI's healthcare products, Hyro, Infinitus and specialized revenue-cycle automation vendors. Buyers will focus on auditability, error rates and the burden of integrating with legacy practice systems.
-
Hippocratic AI adjacent
Healthcare-focused generative agents and patient communications.
-
Hyro direct
Conversational AI for healthcare access and operations.
-
Infinitus direct
Voice automation for healthcare administrative workflows.
Industries
Market / IPO context
Editorial / static context — not a live quote.
Related funding articles
Venture Capital Tracker pieces that cover Confido Health's financing or category context.
FAQs about Confido Health
Practical answers founders, operators, and investors typically search for.
Last updated:
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.